ValiRx PLC - Nuneaton, England-based drug development company - Announces that the broker option granted to Turner Pope Investments Ltd has been fully subscribed and raises £1.0 million before expenses.

Current stock price: 10.97 pence, up 2.1% on Tuesday in London

12-month change: down 43%

Copyright 2022 Alliance News Limited. All Rights Reserved.